ANALYSIS OF THE RATIONALITY OF ANTIPLATELET USE IN ISCHEMIC STROKE PATIENTS AT “X” HOSPITAL, SEMARANG CITY
Main Article Content
Abstract
Ischemic stroke accounts for approximately 85% of all stroke cases and remains a major global health problem. Antiplatelet agents are key for secondary prevention, but irrational use may reduce effectiveness and increase bleeding risk. This retrospective descriptive study evaluated the rationality of antiplatelet use in ischemic stroke patients at “X” Hospital, Semarang City, from January to July 2024. Patients aged ≥26 years with complete medical records were included. Rationality was assessed based on PNPK Stroke Guidelines (2019), AHA/ASA Guidelines (2021), and AHFS Drug Information (2024) using three indicators: appropriate drug, dose, and patient. A total of 111 patients (113 cases) met the inclusion criteria. Most were male (58.56%) and aged >65 years (36.04%), with hypertension, diabetes, and hyperlipidemia as common comorbidities. Aspirin was the most used monotherapy (38.05%), and aspirin–clopidogrel the most frequent combination (37.17%). Drug selection accuracy was high (96.46%), while dose accuracy was low (44.25%). Antiplatelet use at “X” Hospital demonstrated rational drug selection but suboptimal dosing. Improved adherence to dosing guidelines and periodic prescription review are needed to enhance patient safety and treatment outcomes.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
American Society of Health System Pharmacists (2024) AHFS Drug Information 2024
Andrajati R, Kusumawardani LA, Afifah IN, Risni HW (2024) Analysis of drug-related problems in ischemic stroke in-patients in one Indonesian district hospital. Pharm Educ 24:134–139. https://doi.org/10.46542/pe.2024.242.134139
Ariani RR, Amalia L, Gunadharma S, Anggadiredja K (2023) Studi Efikasi dan Pemantauan Reaksi Obat Merugikan dari Antiplatelet pada Pasien Pasca Stroke Iskemik di RSUP dr. Hasan Sadikin Bandung. J Sains dan Kesehat 5:850–859. https://doi.org/10.25026/jsk.v5i5.1944
Arin Nurtya, Artaria Tjempakasari, Ummi Maimunah, Sulistiawati, I Made Subhawa Harsa (2023) Hypertension and Lipid Profiles in Middle-Aged Male Patients: A Study at a Tertiary Hospital in Surabaya, Indonesia. Folia Medica Indones 59:321–328. https://doi.org/10.20473/fmi.v59i4.49674
Aulyra Familah, Arina Fathiyyah Arifin, Achmad Harun Muchsin, Mochammad Erwin Rachman, Dahliah (2024) Karakteristik Penderita Stroke Iskemik dan Stroke Hemoragik. Fakumi Med J J Mhs Kedokt 4:456–463. https://doi.org/10.33096/fmj.v4i6.468
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., 3rd, Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., Levine, D. A., Love, M., Miller, E., Nguyen-Huynh, M., Rasmussen-Winkler, J., Rexrode, K. M., Rose PK
(2024) 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 55(12), e344–e424
Hen, H. S., Cui, Y., Wang, X. H., Ma, Y. T., Han, J., Duan, Y. J., Lu, J., Shen, L. Y., Liang, Y., Wang, W. Z., Wang, H., Zhao, Y., Zhang, J. T., Song, Y. L., He, X. M., Li, R. H., Tao, D. B., Li, J., Huang, S. M., Wang, N. … ATAMIS investigators (2024) Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial. JAMA Neurol
Kemenkes RI (2023) FORMULARIUM NASIONAL
Kemenkes RI (2019) Pedoman Nasional Pelayanan Kedokteran Tata Laksana Stroke. Sustain 11:1–14
Kemenkes RI (2011) Modul Penggunaan Obat Rasional 2011. Modul Pengguna Obat Rasional 3–4
Lengga (2023) 6.+A-Review+Profil+pengobatan+stroke_Hasil-1. profil pengobatan Strr pada pasien rawat Ina di Rumah Sakit X kota Malang periode januari sampai desember 2021 2:4578–4586
Makkiyah FA, Dicha S, Nurrizzka RH (2023) A Single-Center Experience of Correlation of Pulse Pressure to Mortality of Stroke Hemorrhage Patients in Indonesia. Sci World J 2023. https://doi.org/10.1155/2023/5517493
MohanKumar SMJ, Murugan A, Palaniyappan A, MohanKumar PS (2023) Role of cytokines and reactive oxygen species in brain aging. Mech Ageing Dev 214:1–26. https://doi.org/10.1016/j.mad.2023.111855
Nadhifah TA, Sjarqiah U (2022) Gambaran Pasien Stroke Pada Lansia di Rumah Sakit Islam Jakarta Sukapura Tahun 2019. Muhammadiyah J Geriatr 3:23. https://doi.org/10.24853/mujg.3.1.23-30
Oliveira AB de, Muhith A, Zahro C (2023) Risk Factors Of Stroke: Literature Review. J Appl Nurs Heal 5:347–354. https://doi.org/10.55018/janh.v5i2.166
Ruslim D, Destra E, Kurniawan J, Firmansyah Y (2023) Pengaruh Kadar High Density Lipoprotein (HDL) dan Usia terhadap Kejadian Peripheral Arterial Disease (PAD). Termom J Ilm Ilmu Kesehat dan Kedokt 1:180–190
Safouris A, Psychogios K, Palaiodimou L, Orosz P, Magoufis G, Kargiotis O, Theodorou A, Karapanayiotides T, Spiliopoulos S, Nardai S, Sarraj A, Nguyen TN, Yaghi S, Walter S, Sacco S, Turc G, Tsivgoulis G (2024) Update of Anticoagulation Use in Cardioembolic Stroke With a Special Reference to Endovascular Treatment. J Stroke 26:13–25. https://doi.org/10.5853/jos.2023.01578
Tamara FD (2023) Hubungan Konsumsi Antiplatelet Dengan Kejadian Perdarahan Intrakranial. Heal Inf J Penelit 15:e1077–e1077
Venketasubramanian N, Yudiarto FL, Tugasworo D (2022) Stroke Burden and Stroke Services in Indonesia. Cerebrovasc Dis Extra 12:53–57. https://doi.org/10.1159/000524161
World Stroke Organization (2022) Global Stroke Fact Sheet 2022 Purpose : Data sources : World Stroke Organ 13:1–14
Xie S, Peng S, Zhao L, Yang B, Qu Y, Tang X (2025) A comprehensive analysis of stroke risk factors and development of a predictive model using machine learning approaches. Mol Genet Genomics 300:1–15. https://doi.org/10.1007/s00438-024-02217-3
